mRNA Vaccines and Therapeutics Market PDF: Industry Overview, Growth Rate

1. Global mRNA Vaccines and Therapeutics Market Research and Forecast Report 2021-2026 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global mRNA Vaccines and TherapeuticsMarket Research Report: According to the latest report by IMARC Group, titled "mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global mRNA vaccines and therapeutics market size is expected to reach US$ 9.41 Billion in 2021. Messenger Ribonucleic Acid (mRNA) is a single-stranded RNA molecule that plays a vital role in human biology, especially in protein synthesis. Numerous mRNA vaccines and therapeutics are now available in the market that are administered in the human body to trigger virus-detecting immune sensors. This is executed to induce the production of antibodies that further bind to the potential pathogens. These solutions use genetic information to produce viral antigen proteins within the cells and provide acquired immunity through an RNA containing vector, such as lipid nanoparticles. Their use aids in boosting the immunity of the body by improving B- and T-cell responses. Request Free Sample Report: https://www.imarcgroup.com/mrna-vaccines-therapeutics- market/requestsample

4. Report Description and Highlights Report Description Global mRNA Vaccines and Therapeutics Market Trends : mRNA vaccines represent a promising alternative to conventional vaccines due to their high potency, capacity for rapid development and potential for low-cost manufacture. Along with this, there has been a rise in the requirement of vaccines and therapeutics for the treatment of various viral infections, such as Ebola and Human Immunodeficiency Virus (HIV). Since these therapeutics are considered to be more effective against pathogens due to their enhanced immunogenicity, numerous private and public companies are heavily investing in extensive research and development (R&D) activities in the field of biotechnology for vaccine development and protein replacement therapy using mRNA. Additionally, on account of the outbreak of the coronavirus disease (COVID-19) pandemic, numerous companies are currently engaging in the development of a vaccine to curb the transmission of the virus, thereby creating a positive outlook for the market. Moderna, Inc. is one such leading mRNA technology firm that is actively invested in the development of the mRNA-1273 vaccine against the novel coronavirus (SARS-CoV-2). It has registered positive interim results in its Phase 1 study and has already proceeded with the Phase 3 study of mRNA-1273 that is being conducted in collaboration with the NIH and BARDA. The market is further driven by the significant improvements in the lipid nanoparticle formulations for in-vivo systemic delivery of mRNA. On account of the aforementioned factors, the market is anticipated to register a CAGR of 10.5% during 2021-2026, reaching a value of US$ 15.49 Billion by 2026.

5. Report Description and Highlights Report Description Market Summary: Breakup by Vaccine Type: •Self-amplifying mRNA-based Vaccines •Conventional Non-Amplifying mRNA-Based Vaccines Breakup by Treatment Type: •Bioengineered Vaccine •Gene Therapy •Gene Transcription •Cell Therapy •Monoclonal Antibody •Others Breakup by Vaccine Manufacturing: •In-House •Out-Sourced

6. Report Description Report Description and Highlights Breakup by Application: •Cancer •Infectious Disease •Gene Editing •Protein Replacement Breakup by End-User: •Hospitals and Clinics •Research Organizations •Others Breakup by Region: •North America • United States • Canada •Asia Pacific • China • Japan • India • South Korea

7. Report Description Report Description and Highlights • • • Australia Indonesia Others •Europe • • • • • • • Germany France United Kingdom Italy Spain Russia Others •Latin America • • • • • • • Brazil Mexico Argentina Columbia Chile Peru Others

8. Report Description Report Description and Highlights •Middle East and Africa Turkey •Saudi Arabia •Iran •United Arab Emirates •Others Competitive Landscape with Key Players: • Arcturus Therapeutics Inc. • BioNTech SE • CureVac AG • Etherna • ethris GmbH • GlaxoSmithKline PLC • Moderna Therapeutics Inc. • Translate Bio Inc. • Argos Therapeutics, Inc. • Sangamo Therapeutics Inc. • Pfizer Inc View Full Report with TOC & List of Figure: https://www.imarcgroup.com/mrna-vaccines-therapeutics- market

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

11. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

12. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com